EGF-receptor targeting with monoclonal antibodies in colorectal carcinomas: rationale for a pharmacogenomic approach

By Loupakis Fotios   Vasile Enrico   Santini Daniele   Masi Gianluca   Falcone Alfredo   Graziano Francesco  

Pharmacogenomics, Vol. 9, Iss. 1, 2008-01 ,pp. : 55-69

Future Medicine

Access to resources Recommend Favorite

Therapeutic targeting of receptor tyrosine kinases in lung cancer

By Choong Nicholas W   Ma Patrick C   Salgia Ravi  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 533-559

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Adhesion Force and Binding Affinity of Phytohemagglutinin Erythroagglutinating to EGF Receptor on Human Lung Cancer Cells

By  

Current Medicinal Chemistry, Vol. 20, Iss. 19, 2013-06 ,pp. : 2476-2485

Bentham Science Publishers

Access to resources Recommend Favorite

Compounds and methods for the treatment of EGF receptor associated cancers and purification of the EGF receptor

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 8, 1997-08 ,pp. : 895-897

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in the Treatment of Colorectal Cancer: State of the Art

By Diasio Robert B.   Fourie Jeanne  

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1441-1463

Adis International

Access to resources Recommend Favorite